Fig. 11From: Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemiaGSEA analysis between low and high SRP14 phenotypes in GSE12417 cohort using the C2 reference gene set. a FGFR in disease; b signaling by ROBO receptors; c signaling by FGFR2 in disease; d FGFR2 alternative splicing; e FGFR2 mutant receptor activation; and f Tumor differentiated well vs poorly upBack to article page